1Derosa G, Ferrari I, Cicero AF. Irbesartan and hydrochlorothiazide association in the treatment of hypertension. Pharmacol, 2009,7 ( 2 ) : 120.
2Antonio C, Carlos C, Garcta - Puig J, et al. A muhicenter, random- ized, double - blind comparison of the efficacy and safety of irbesar- tan and enalapril in adults with mild to moderate essential hyperten- sion, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study. Clin Ther ,2002 ,24 ( 1 ) : 126.
3USP 34. 2011 年 :799.
4Vanessa A ,Sophie L, Miche M, et al. Microbial models of animal drug metabolism Part 5. Microbial preparation of human hydroxylated metabolites of irbesartan. J Mol Catal B - Enzym,2004,29 (12) : 173.
5Theodore J, Donald W, Alicia D, et al. Biotransformation of irbesartan in man. Drug Metab Dispos, 1998,26 (5) :408.
6Ravi P, Archana S, Saranjit S. Identification and characterization of degradation products of irbesartan using LC -MS/TOF, MS, on -line I-I/D exchange and LC - NMR. J Pharm Biomed Anal, 2010,51 (5) :1037.
7Stanislav R, Jan S, Jaroslav H, et al. Synthesis and identification of some impurities of irbesartan. Acta Chim Slov ,2009,56( 1 ) :599.
8Satyanarayana B, Anjaneyulu Y, Veerasomaiah P, et al. Synthesis and characterization of irbesartan impurities. Heterocycl Commun, 2011, 13(4) :223.
